Lukas Scheibler - Jun 10, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Stock symbol
APLS
Transactions as of
Jun 10, 2021
Transactions value $
-$205,020
Form type
4
Date filed
6/11/2021, 04:07 PM
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$205K -3.42K -11.36% $60.00 26.7K Jun 10, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 778 shares from 04/30/21 ESPP Purchase.
F2 This is a scheduled sale from 10B5-1 trading plan.